Feline Urinary Tract Infection (Bacterial Cystitis)

Feline bacterial urinary tract infection (bacterial cystitis) refers to the colonization and proliferation of bacteria within the urinary bladder of cats, resulting in inflammation of the bladder wall and associated lower urinary tract signs [1]. Unlike dogs, true bacterial UTI is relatively uncommon in cats overall, but it represents a clinically important subset of feline lower urinary tract disease (FLUTD), particularly in older cats and those with underlying predisposing conditions [3]. The incidence increases markedly in female cats and in cats over 10 years of age, in whom host defense mechanisms may be compromised [3][4]. Because bacterial cystitis shares clinical signs with other causes of FLUTD—such as feline idiopathic cystitis (FIC) and urolithiasis—definitive microbiological diagnosis is essential before antimicrobial therapy is initiated [1][2].

Causative Organisms

Bacterial cystitis in cats is most frequently caused by gram-negative enteric organisms, with Escherichia coli being the predominant isolate across multiple studies [3][7]. Other commonly identified pathogens include Staphylococcus spp., Streptococcus spp., Enterococcus spp., Pasteurella spp., Klebsiella spp., Proteus spp., and Pseudomonas spp. [2][7]. Fungal organisms (e.g., Candida spp.) are rare but documented causes, typically in immunocompromised or diabetic patients [2].

Pathophysiological Mechanism

The healthy feline urinary tract possesses robust defense mechanisms that resist bacterial colonization, including high urine osmolality, acidic urine pH, normal micturition frequency (which flushes bacteria), glycosaminoglycan (GAG) mucosal barrier integrity, secretory IgA, and local cell-mediated immunity [2][3]. Bacterial cystitis develops when one or more of these defenses are compromised and a virulent organism gains access to the bladder, typically via ascending contamination from the urethra and perineal environment [1][2].

Host Risk Factors

Predisposing conditions significantly increase susceptibility [1][3]:

• ·Advanced age (>10 years): reduced immune competence and often concurrent systemic disease
• ·Female sex: shorter, wider urethra facilitates ascending bacterial migration
• ·Diabetes mellitus: glucosuria provides bacterial substrate; impaired neutrophil function
• ·Chronic kidney disease (CKD): dilute urine with reduced bacteriostatic properties
• ·Hyperthyroidism and hyperadrenocorticism: immunosuppression and altered urine concentration
• ·Urolithiasis or bladder masses: structural disruption of mucosal integrity and urine flow
• ·Perineal urethrostomy: surgically shortened urethra removes a major anatomical defense
• ·Indwelling urinary catheters: direct conduit for ascending infection and biofilm formation
• ·Corticosteroid or immunosuppressive therapy: impairs local and systemic immune responses

Bacterial Virulence

Uropathogens like E. coli express specific virulence factors—including type 1 and P fimbriae, iron-acquisition systems, and toxins—that facilitate adhesion to urothelial cells, evasion of phagocytosis, and persistence despite urine flow [2]. Once adhered, bacteria multiply and trigger an inflammatory cascade involving neutrophil infiltration, cytokine release (IL-1β, IL-6, TNF-α), and mucosal edema, which collectively produce the classic signs of lower urinary tract inflammation [2][8].

Clinical Suspicion

Diagnosis begins with recognition of FLUTD signs in an at-risk cat (older, female, or with concurrent disease) [3][4]. Younger cats presenting with FLUTD are statistically more likely to have idiopathic cystitis or urolithiasis than true bacterial infection [4].

Urinalysis

Complete urinalysis (specific gravity, dipstick chemistry, sediment examination) is the first-line diagnostic step [1][2]:

• ·Urine specific gravity: may be low (<1.025) in cats with CKD or other polyuric conditions, which itself is a predisposing factor
• ·Dipstick: hematuria (blood), proteinuria, and a positive leukocyte esterase reaction suggest inflammation; however, leukocyte esterase has low sensitivity in feline urine and should not be used as a standalone test
• ·Sediment examination: the presence of >5 white blood cells (WBC) per high-power field (pyuria), bacteriuria, and hematuria constitutes strong cytological evidence of UTI
• ·Protein profile: urine from cats with bacterial UTI shows a distinct protein profile compared to idiopathic cystitis and urolithiasis, though protein analysis is primarily a research tool [8]

Urine Culture and Sensitivity (Gold Standard)

Quantitative urine culture is the definitive diagnostic test and is mandatory before antibiotic selection [1][2]. Urine should ideally be collected by cystocentesis to avoid urethral and prepucial contamination [1]. Interpretation thresholds:

• ·Cystocentesis: ≥1,000 CFU/mL is considered significant; some guidelines accept lower thresholds with concurrent pyuria [1]
• ·Catheterization: ≥10,000 CFU/mL
• ·Free-catch (midstream): ≥100,000 CFU/mL, though this method is less reliable in cats

Antimicrobial susceptibility testing (AST) from culture guides targeted therapy and is critical given rising antimicrobial resistance patterns [1][6].

Advanced Identification Methods

MALDI-TOF mass spectrometry (using systems such as the MALDI BioTyper) has been validated for rapid identification of uropathogens from feline urine samples, offering accurate bacterial identification within hours compared to conventional culture methods [7]. This technology is particularly useful in referral or specialty practice settings.

Imaging

• ·Abdominal radiography or ultrasonography: recommended to identify predisposing structural abnormalities such as uroliths, bladder wall thickening, masses, ureteral dilation (suggesting pyelonephritis), or anatomical anomalies [1][2]
• ·Contrast cystography: occasionally used when structural lesions are suspected but not visualized on survey imaging

Laboratory Blood Work

In uncomplicated bacterial cystitis, CBC and serum chemistry are typically normal. However, they are important to screen for underlying or concurrent conditions:

• ·CBC: leukocytosis (elevated WBC) with a left shift may indicate ascending infection or concurrent systemic illness; anemia (low HCT) may reflect CKD or chronic inflammation
• ·BUN and CREA (creatinine): elevated in concurrent CKD or pyelonephritis with renal compromise
• ·ALT: may be elevated if hepatic involvement or concurrent liver disease is present
• ·ALB (albumin): hypoalbuminemia can indicate protein-losing conditions complicating UTI
• ·GLOB (globulins): may be elevated with chronic infection or immune stimulation
• ·PLT (platelets): generally normal in uncomplicated UTI; thrombocytopenia could suggest sepsis if severe systemic infection develops
• ·Blood glucose: essential to screen for diabetes mellitus as a predisposing cause

Subclinical Bacteriuria

Some cats—particularly those with CKD or other chronic diseases—may have positive urine cultures in the absence of clinical signs. This entity, termed subclinical bacteriuria (SB), is of uncertain clinical significance, and current guidelines do not routinely recommend antibiotic treatment for SB in cats unless specific risk factors (e.g., planned urinary surgery) are present [1][3].

Principles of Antimicrobial Therapy

Treatment of bacterial cystitis should always be guided by urine culture and susceptibility results [1][2]. Empirical therapy—initiated before culture results are available—should be based on knowledge of likely pathogens and local resistance patterns, and must be reassessed once culture data are returned [1][6]. A multicenter study found that antimicrobial prescribing practices in cats diagnosed with bacterial UTI frequently deviated from guideline recommendations, underscoring the importance of culture-guided therapy [6].

Antibiotic Selection

For uncomplicated sporadic bacterial cystitis in cats, ISCAID guidelines recommend [1]:

• ·Amoxicillin (11–15 mg/kg PO q8–12h): first-line empirical choice; narrow spectrum, good efficacy against common uropathogens, achieves high urinary concentrations
• ·Trimethoprim-sulfonamide (15 mg/kg PO q12h): alternative first-line option; broad spectrum with good urinary penetration
• ·Amoxicillin-clavulanate: suitable when beta-lactamase-producing organisms are suspected or confirmed on culture; slightly broader spectrum than amoxicillin alone

The following agents should generally be reserved for culture-confirmed resistant infections or when first-line drugs are inappropriate, in order to preserve antimicrobial efficacy and minimize resistance development [1][6]:

• ·Fluoroquinolones (e.g., enrofloxacin, marbofloxacin): critically important antimicrobials; restrict to cases confirmed resistant to first-line options
• ·Third-generation cephalosporins (e.g., cefpodoxime): reserve use similarly

Treatment Duration

• ·Sporadic uncomplicated bacterial cystitis: 7 days of antibiotic therapy [1]
• ·Complicated UTI (e.g., concurrent structural disease, immunocompromise, recurrent infection): 4 weeks or longer depending on the nature of the complication [1][2]
• ·Pyelonephritis: minimum 4 weeks, with consideration of parenteral therapy in severe cases [1]
• ·Subclinical bacteriuria: treatment is generally NOT recommended unless specific indications exist [1][3]

Recurrent Bacterial Cystitis

Recurrent UTI (≥3 episodes in 12 months, or ≥2 episodes in 6 months) warrants [1]:

1. ·Thorough investigation for and correction of underlying predisposing factors
2. ·Each episode treated based on individual culture results, as the causative organism and resistance profile may change
3. ·Consideration of long-term prophylactic low-dose antimicrobial therapy only in specific refractory cases after all predisposing factors have been addressed

Management of Predisposing Conditions

Effective treatment requires addressing underlying diseases [2][3]:

• ·Optimization of glycemic control in diabetic cats
• ·Medical or surgical management of urolithiasis
• ·Removal or repositioning of indwelling urinary catheters when feasible
• ·Dose reduction or discontinuation of immunosuppressive drugs if possible

Supportive and Dietary Management

• ·Increased water intake: promoting hydration through wet food diets or water fountains dilutes urine, reduces bacterial concentrations, and increases micturition frequency, thereby enhancing mechanical flushing of bacteria [5]
• ·Dietary modification: therapeutic diets that modify urine pH and concentration may reduce recurrence risk, particularly when concurrent urolithiasis is present [5]
• ·Urinary acidifiers or alkalinizers: occasionally used as adjuncts based on the struvite or calcium oxalate stone type
• ·Anti-inflammatory analgesics: may be considered short-term for pain relief in cats with marked dysuria, although evidence for routine use is limited

Urinary Catheters

Indwelling urinary catheters should be maintained with strict aseptic technique, and catheter-associated UTI should be treated with culture-directed antibiotics [1]. Prophylactic antibiotic therapy solely for catheter placement is not recommended [1].

General Prognosis

The prognosis for cats with uncomplicated sporadic bacterial cystitis is excellent, with the majority of cases resolving completely with appropriate culture-directed antimicrobial therapy [1][2]. Bacterial cystitis confined to the lower urinary tract is not directly associated with mortality in otherwise healthy cats.

Mortality Considerations

The available literature on feline bacterial cystitis does not provide explicit overall mortality rate statistics for this condition as an isolated entity [1][2][3]. Bacterial cystitis per se carries an extremely low case-fatality risk in cats without severe systemic disease. However, mortality risk increases substantially in specific clinical contexts:

• ·Ascending pyelonephritis with sepsis or acute kidney injury can be life-threatening, particularly in cats with pre-existing CKD where renal reserve is limited [2]
• ·Urosepsis secondary to UTI, though rare, carries a guarded to poor prognosis
• ·Cats with concurrent severe systemic disease (advanced CKD, uncontrolled diabetes, immunosuppression) have a prognosis that is determined more by the underlying condition than by the UTI itself [3]

Recurrence and Complications

• ·Cats with underlying structural or metabolic predisposing factors are at high risk for recurrence and may require long-term management [1][3]
• ·Treatment failure may occur due to antimicrobial resistance, persistence of predisposing factors, or the presence of a biofilm-forming organism resistant to standard antibiotic concentrations
• ·Failure to perform urine culture before or during treatment is a leading cause of treatment failure and contributes to the emergence of multidrug-resistant uropathogens [1][6]

Post-Treatment Monitoring

A follow-up urine culture 5–7 days after completing antibiotic therapy is recommended to confirm bacteriological cure, particularly in complicated or recurrent cases [1][2]. Resolution of clinical signs alone does not reliably confirm bacterial elimination.

Minimizing Risk Factors

The most effective preventive strategy is identification and management of conditions that impair host urinary defenses [1][3]:

• ·Management of chronic diseases: optimal control of diabetes mellitus, CKD, hyperthyroidism, and hyperadrenocorticism reduces the risk of secondary UTI
• ·Minimizing immunosuppressive therapy: use the lowest effective dose of corticosteroids or other immunosuppressants when possible
• ·Avoidance of unnecessary urinary catheterization: catheters should be placed only when clinically indicated and removed at the earliest opportunity; strict aseptic technique is mandatory when catheterization is required [1]

Dietary and Husbandry Measures

• ·Promoting hydration: feeding wet (canned) diets and providing fresh water in multiple locations or via water fountains increases urine volume and voiding frequency, reducing bacterial residence time in the bladder [5]
• ·Therapeutic diets: specialized urinary diets that maintain appropriate urine dilution and pH may reduce the risk of concurrent struvite urolithiasis, a recognized predisposing structural factor [5]
• ·Litter box hygiene: maintaining a clean, accessible litter box encourages frequent urination and reduces perineal bacterial burden

Antimicrobial Stewardship

Given that UTI is one of the most common indications for antimicrobial use in veterinary medicine, responsible antibiotic prescribing is a critical preventive consideration at the population level [3][6]:

• ·Avoid empirical treatment without urine culture confirmation
• ·Use narrow-spectrum, first-line agents when possible
• ·Adhere to recommended treatment durations to minimize selection pressure for resistant organisms [1][6]

Vaccination

No vaccines are currently available for prevention of bacterial UTI in cats. Prevention relies entirely on the husbandry, dietary, and medical management strategies described above.

Screening in High-Risk Cats

Periodic urinalysis and urine culture in cats with known predisposing conditions (CKD, diabetes mellitus, perineal urethrostomy) may facilitate early detection and treatment before clinical signs develop, though the benefit of treating asymptomatic bacteriuria remains debated in current literature [1][3].